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ABSTRACT
ZBP-89 (Zfp148, ZNF148) is a Kruppel-type zinc-finger family transcription factor 
that binds to GC-rich DNA elements. Earlier studies in cell lines demonstrated that ZBP-
89 cooperates with Wnt β-catenin signaling by inducing β-catenin gene expression. 
Since β-catenin levels are normally highest at the crypt base, we examined whether 
ZBP-89 is required for stem cell maintenance. Lineage-tracing using a Zfp148CreERT2 
transgenic line demonstrated expression in both intestine and colonic stem cells. 
Deleting the Zfp148 locus in the colon using the Cdx2NLSCreERT2 transgene, reduced 
the size and number of polyps formed in the Apc-deleted mice. Since colon polyps form 
in the presence of butyrate, a short chain fatty acid that suppresses cell growth, we 
examined the direct effect of butyrate on colon organoid survival. Butyrate induced 
senescence of colon organoids carrying the Apc deletion, only when Zfp148 was 
deleted. Using quantitative PCR and chromatin immunoprecipitation, we determined 
that butyrate treatment of colon cell lines suppressed ZNF148 gene expression, 
inducing CDKN2a (p16Ink4a) gene expression. Collectively, Zfp148 mRNA is expressed in 
CBCs, and is required for stem cell maintenance and colonic transformation. Butyrate 
induces colonic cell senescence in part through suppression of ZBP-89 gene expression 
and its subsequent occupancy of the CDKN2A promoter.
INTRODUCTION
Zinc Finger Binding Protein-89 kDa (ZBP-89, 
human ZNF148 or mouse Zfp148 loci) is a ubiquitously 
expressed Krüppel-type zinc finger transcription factor 
that binds GC-rich DNA elements [1, 2]. We previously 
showed that histone deacetylase inhibition (HDACi), 
e.g., with butyrate or trichostatin A (TSA) contributes to 
ZBP-89 induction of CDKN1B (p21Waf1) and its protein-
protein interaction with tumor suppressor proteins p53, 
ataxia telangiectasia mutated (ATM), and p300, a histone 
acetyltransferase (HAT) [2-4]. In addition, ZBP-89 
mediates transcriptional repression of the vimentin and 
CDKN2A (p16INK4A) genes by recruiting HDACs to their 
promoters [5-7]. ZBP-89 induces tryptophan hydroxylase 
(Tph1) by synergizing with β-catenin, and contributes to 
the mucosal defense against S. typhimurium [8]. Having 
established that ZBP-89 and β-catenin cooperate in normal 
colonic mucosal restitution, we tested and found that ZBP-
89 contributes to intestinal polyp formation initiated by 
deletion of the Apc locus [9].
Conditional deletion of the Zfp148 locus in 
intestinal epithelial cells reduced the expected number 
of small intestinal polyps in a mouse model of deleted 
Apc, demonstrating that ZBP-89 is required for β-catenin-
dependent polyp formation [9]. We found that β-catenin 
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binds to the ZNF148 promoter stimulating ZBP-89 
gene expression. Similarly, ZBP-89 protein binds to 
the CTNNB1 (β-catenin) promoter inducing β-catenin 
transcription. In this way, ZBP-89 contributes to a 
feedforward gene expression loop that can maintain 
elevated levels of β-catenin when and where Wnt signaling 
is high [9], such as in the normal stem cell niche and in 
colon cancer. Accordingly, we also showed that ZBP-89 
expression correlates with poor survival after surgical 
resection for colorectal cancer and that ZBP-89 protein 
expression is elevated in colorectal cancer (CRC) [9].
In both the intestine and colon, Wnt signaling is 
highest at the base of the glands or crypts suggesting that 
ZBP-89 might play an essential role in the stem cell niche. 
To test this hypothesis directly, we studied the expression and 
function of ZBP-89 in intestinal and colonic stem cells and 
found that the transcription factor is expressed in the crypt 
basal columnar cells (CBCs) that eventually differentiate and 
repopulate the small intestine and colon glands. Moreover, 
ZBP-89 is also required for polyp growth in the colon of 
hemizygous Apc (Cdx2Cre:ApcFL/+) mice. To study the effect 
of a common bacterial metabolite on stem cell maintenance, 
colonic organoids generated from wild type (WT) and 
Cdx2Cre:ApcFL/+ mouse colons were cultured in the presence 
of the short-chain fatty acid (SCFA) butyrate. We found 
that organoids generated from the Cdx2Cre:ApcFL/+ colon 
retain their stem cell phenotype in the presence of butyrate. 
However, deleting Zfp148 decreased colonic organoid 
growth and allowed the organoids to senesce. Collectively, 
our results demonstrate that ZBP-89 plays a role in stem 
cell differentiation during homeostasis and transformation 
through its ability to suppress senescence.
RESULTS
ZBP-89 protein is highly expressed in CBCs and 
transit-amplifying (TA) cells
To determine the mucosal location of ZBP-89 protein 
expression in the luminal gastrointestinal tract, we performed 
immunohistochemistry (IHC) on tissue from the small intestine 
(duodenum, jejunum and ileum) and colon (proximal and distal 
colon). In the small intestine, ZBP-89 protein was expressed 
primarily in the transit-amplifying (TA) cells and in scattered 
cells at the crypt base (Figure 1A). Expression diminished at the 
villus tip, where senescent cells slough into the lumen. In the 
Figure 1: ZBP-89 is highly expressed in CBCs and TA cells. Representative images of immunohistochemistry for ZBP-89 in the 
(A) small intestine and (B) colon. (C) Zfp148 in situ hybridization in the small intestine. The sense probe was used as the negative control. 
Scale bar=100μm. Inset of CBCs at 200μm
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cecum and colon (proximal and distal), ZBP-89 was expressed 
in the lower two-thirds of the colonic gland base (Figure 1B). 
In addition, ZBP-89 is a ubiquitous protein that is also highly 
expressed in immune cells [10, 11], accounting for expression in 
scattered cells of the lamina propria.
To localize Zfp148 mRNA, we performed in situ 
hybridization (ISH) in the small intestine and found 
that the highest level of mRNA expression occurred at 
the crypt base (Figure 1C). Scattered cells in the lamina 
propria also expressed Zfp148 mRNA, consistent with its 
known expression in immune cells (Figure 1) [10].
Zfp148+ cells lineage trace in small intestine and 
colon
Since Zfp148 mRNA was expressed at the base of the 
crypts in CBCs, we generated a Zfp148CreERT2 line from a 
BAC clone containing 250 kb of the Zfp148 promoter to 
lineage trace its expression. The Zfp148: tdTomato hybrid 
mice were injected with one dose of tamoxifen (Tx) and 
then were euthanized at 24h, 3d, 1 week and 3 weeks post 
injection. At 24h post Tx injection, Zfp148 positive cells 
resided at the base of the small intestine and colonic crypts 
(Figure 2A, 2E). By day 3, the intestinal crypt base and 
transit-amplifying (TA) cells were consistently labeled 
(Figure 2B, 2F). By 7d post injection, the tdTomato+ 
(tdTpos) cells populated not only the crypts and TA zone but 
also labeled scattered cells at the tip of the villi (Figure 2C, 
2G). After 3 weeks, Zfp148 positive cells formed stripes 
along the entire villus and colonic glands (Figure 2D, 2H). 
As previously observed for the Lgr5-EGFP-CreERT2 reporter 
[12], we also found that the Zfp148CreERT2 plasmid also 
generated a variegated lineage trace. While the variegation 
might indicate stem cell heterogeneity, recent modifications 
Figure 2: Lineage trace of Zfp148 in mouse small intestine and colon. Representative pictures of Zfp148 lineage trace using 
Zfp148: tdTomato chimeric mice IP injected with one dose of tamoxifen 0.1mg/g body weight (Tx). The small intestine was examined after 
24h (A), 3 days (B), one week (C) and three weeks (D). The colon was examined after 24h (E), 3 days (F), one week (G) and three weeks 
(H). (I-L) Confocal images of intestinal organoids cultured over 10 days after generating from the Zfp148: tdTomato mouse injected with 
one dose of Tamoxifen and euthanized after 24h. N=4 mice analyzed per time point. Scale bar=100 μm.
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to the original Lgr5 reporter (Lgr5-2A-EGFP-CreERT2) 
created non-variegated lineage tracing, which suggests that 
the patchy expression is related to transcript stability [13]. 
Intestinal glands were harvested 24h post Tx injection from 
the chimeric Zfp148:tdT mice and cultured for 10 days in 
Matrigel to generate Zfp148:tdTpos organoids. Two days 
after culture, a few Zfp148:tdTpos cells were visible in the 
spherical organoids (Figure 2I). By day 3, the Zfp148:tdTpos 
cells localized to the crypt-buds and onto the villus-like 
domain (Figure 2J). At day 7 and 10, Zfp148:tdTpos cells 
were predominantly located in the crypt-like structures and 
in the organoid lumen (Figure 2K, 2L). Thus, we concluded 
Figure 3: Single cell sorting of Zfp148: tdTomato+ cells and deletion of Zfp148 in stem cells. (A) Single cell sorting of Zfp148: 
tdTomato positive cells from the small intestine and colon. Gate of fluorescent cells isolated from the CreNeg versus Zfp148CreERT2+ mice 
24h after one dose of Tx (0.1mg/g body weight). Shown is the median percentage ±SEM for tdTomato+ sorted cells from N=3 mice per 
tissue per genotype. (B) Representative images of sorted cells cultured in Matrigel after 3 days in culture. (C) Graph showing total number 
of small intestine organoids per day. Shown is the mean ±SEM. *** P< 0.0001 ANOVA with Tukey’s multiple comparisons. N=3 passages of 
organoids pooled from 3 mice and cultured in triplicate per time point. Arrow indicates the addition of 4-OH-Tx added after the organoids 
were in culture for 3 days. Scale bars =100μm.
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that Zfp148:tdTpos cells are highly expressed in the CBC 
stem cells and can repopulate the entire villi, indicating that 
ZBP-89 plays a role in both intestine and colonic stem cells.
Zfp148 positive cells form small intestine and 
colonic organoids
To further assess the function of ZBP-89 in small 
intestinal and colonic stem cells, single tdTpos cells 
were sorted from a cell suspension of small intestine or 
colonic mucosa 24h post Tx injection (Figure 3A). Both 
Zfp148tdTpos and Zfp148tdTneg cells isolated from the 
intestine and colon were re-suspended in Matrigel and 
cultured in complete media. Only the Zfp148tdTpos-sorted 
cells were capable of forming organoids (Figure 3B). 
Thus, Zfp148-tdT+ cells from both the intestine and colon 
generated budding organoids that continued to express 
the tdTomato reporter (Figure 3B). To study the function 
of ZBP-89 in the Lgr5+ CBC stem cells, the Zfp148 
locus was deleted by treating the Lgr5CreERT2:Zfp148FL/+ 
and Lgr5CreERT2:Zfp148FL/FL chimeric mouse organoids 
with 4OH-Tx after 3 days in culture. After 48h of 4OH-
Tx treatment, the number of Lgr5CreERT2:Zfp148FL/FL 
organoids were significantly reduced compared to the Cre 
Negative (CreNeg) and Lgr5CreERT2:Zfp148FL/+ (Figure 
3C). Collectively, these results demonstrated that Zfp148 
plays a critical role in the survival of both intestinal and 
colonic stem cells.
Zfp148 deletion reduces tumorigenesis in Cdx2: 
ApcFL/+ mouse colon
To evaluate the impact of ZBP-89 on Apc-mediated 
colon polyps, we generated Cdx2Cre: ApcFL/+: Zfp148FL/FL 
hybrid mice. The Cdx2Cre: ApcFL/+ mice [14] developed 
an average of 15 polyps per colon distributed throughout 
the proximal and distal colon after 5 months (Figure 4A-
4C). The number of colon polyps in the Cdx2Cre:ApcFL/+ 
Figure 4: Deletion of Zfp148 reduces colonic polyps in Cdx2: ApcFL/+ mice. (A) H&E of Swiss rolls from mouse colons from 
Cre Negative; Cdx2: ApcFL/+; Cdx2: ApcFL/+:Zfp148FL/+ and Cdx2: ApcFL/+:Zfp148FL/FL as indicated. Scale bar = 200μm. (B) Representative 
pictures of ZBP-89 IHC in the colon from the mice shown in (A). Scale bars = 200μm. (C) Number of polyps per mouse from the indicated 
genotypes. Shown are means ±SEM. N=9 mice per genotype **P< 0.001, ANOVA Kruskal-Wallis test. (D) Distribution of polyp location 
as a percentage of total number of polyps per genotype. The number in parentheses equals the total number of polyps identified for that 
genotype for the 9 mice. (E) Distribution of polyp size as a percentage of total number of polyps per genotype.
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mice was ~4-fold greater than what we observed when 
the VillinCre transgene was used to delete Apc [9]. In 
the Cdx2Cre: ApcFL/+ mice, loss of one or both Zfp148 
alleles reduced the number of colon polyps by 80% 
(Figure 4C). Moreover, the location of the polyps that did 
emerge was more distal in the Cdx2: ApcFL/+ mice carrying 
deleted Zfp148 loci (Figure 4D) and the polyp size was 
significantly reduced when the Zfp148 alleles were deleted 
(Figure 4E).
Zfp148 deletion permits colon organoid 
differentiation
To directly test the effect of deleting Zfp148 in 
the hemizygous Apc colonic stem cells, organoids were 
generated from the colon of Cdx2Cre: ApcFL/+ mice, 
which showed a non-budding stem cell morphology 
(spherical organoids, Figure 5A). However, loss of one or 
both Zfp148 alleles was sufficient to induce a wrinkled 
appearance after 3 days of culture that progressed to 
small buds by day 7 (Figure 5A, 5B, 5D). When both 
Zfp148 alleles were deleted, the organoids exhibited 
extensive budding demonstrating that ZBP-89 was 
required to maintain stemness. Although loss of one or 
both Zfp148 alleles in the setting of deleted Apc, reduced 
polyp formation, it did not affect the degree of organoid 
proliferation as determined by EdU incorporation (Figure 
5C, 5E). Although ZBP-89 was required for maintenance 
of the stem cell niche and cooperates with Wnt signaling, 
the lack of an effect on cell proliferation suggested 
that synergy with Wnt signaling affected a different 
requirement for stem cell maintenance. Therefore, we 
examined several Wnt targets and found that deletion 
of Zfp148 in the colon decreased the expression of two 
Figure 5: Deletion of Zfp148 induces cell differentiation in Cdx2:ApcFL/+ organoids. (A, B) Images of colonic organoid 
morphology for each genotype after 2 and 7 days in culture (Cre Neg.; Cdx2: Zfp148FL/FL ; Cdx2: ApcFL/+; Cdx2: ApcFL/+:Zfp148FL/+ and 
Cdx2: ApcFL/+:Zfp148FL/Fl). (C) Confocal images of EdU incorporation per genotype after 3 days in culture. Scale bar = 100μm. (D) Mean 
percentage ±SEM for organoid morphology per total structures (organoids/spheroids) at day 2, 3, 5 and 7 after culturing in Matrigel in 
triplicate for three passages from 3 mice per genotype. (E) Mean percentage ±SEM of EdU+ nuclei, using 2-3 organoids per image. Five 
images per genotype per condition were quantified. (F) qPCR using three passages of organoids per genotype. Shown are means ±SEM, 
****P< 0.0001 ***P< 0.001, **P< 0.005, *P< 0.05 by two-way ANOVA Tukey’s multiple comparisons test.
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direct Wnt target genes Lgr5 and Axin2 consistent synergy 
between ZBP-89 and β-catenin. Although Reg4 a Wnt 
target gene was modulated by deletion of Zfp148, it is also 
regulated by Cdx2 and Gata 6 transcription factors [15-
17]. β-catenin mRNA levels were not affected, perhaps 
reflecting steady state levels of the protein that are 
achieved once the organoids become established. Deleting 
Zfp148 also reduced Notch1, suggesting some crosstalk 
with the Notch signaling pathway (Figure 5F).
ZBP-89 prevents Apc-deleted organoids from 
butyrate-induced growth inhibition
Unlike the small intestine, tumors in the colon 
emerge in the presence of commensal bacteria that ferment 
carbohydrates into millimolar amounts of butyrate, a short 
chain fatty acid (SCFA) with the most potent HDAC 
inhibitory activity [18, 19]. Organoid cultures are usually 
carried out in the absence of butyrate or bacteria. Indeed, 
butyrate generally suppresses colonic cell growth, which 
might explain the persistent proliferation of the organoids 
carrying a mutant Apc allele (Figure 5). Therefore, we 
examined whether adding butyrate to the organoid cultures 
affected their growth. Colonic organoids from both WT 
(CreNeg) and Cdx2Cre:Zfp148FL/FL mice were treated with 
0.5mM butyrate, which induced a significant increase in 
apoptotic cells and suppressed cell proliferation compared 
to the group with no butyrate (Figure 6A, 6B). Under these 
conditions, colonic organoids carrying the Apc deletion 
(Cdx2Cre: ApcFL/+) maintained their spheroid shape and 
thrived in the presence of butyrate (0.5mM) even though 
the same concentrations of butyrate were poorly tolerated 
Figure 6: ZBP-89 protects Apc mutant organoids against butyrate treatment. (A, B) Representative pictures of Cre Neg; 
Cdx2:Zfp148FL/FL colonic organoid morphology after 0.1mM and 0.5mM butyrate added to the organoid culture medium (C, D) Cdx2: 
ApcFL/+:Zfp148FL/+ and Cdx2: ApcFL/+:Zfp148FL/Fl organoids after butyrate treatment. (E) Number of organoids per genotype and per butyrate 
concentration for three passages of organoids cultured in triplicate per genotype. Shown are the means ±SEM. ***P= 0.001 using two-way 
ANOVA with Sidak’s multiple comparisons test. (F) Mean percentage ±SEM of EdU+ nuclei from 2-3 colon organoids per image from 
a pool of 3 mice per genotype. **P< 0.001 and ***P< 0.0001 by two-way ANOVA Tukey’s multiple comparisons test. (G) TUNEL assay, 
shown as the percentage of TdT positive cells for each population per number of DAPI positive cells. *P< 0.05, **P< 0.001 and ***P< 0.0001 
by two-way ANOVA Tukey’s multiple comparisons test.
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by normal colon organoids (Figure 6C, 6D). However, 
deletion of Zfp148 (Cdx2Cre: ApcFL/+: Zfp148FL/FL) reduced 
organoid proliferation in the presence of butyrate (Figure 
6E, 6F), but there was no significant increase in apoptosis 
(Figure 6G), suggesting that loss of Zfp148 in the presence 
of butyrate might initiate cellular senescence (growth 
arrest) in contrast to apoptosis [20]. By contrast, intestinal 
organoids exhibited greater sensitivity to butyrate (Figure 
7A-7E). Senescence was observed in the Apc and Apc 
plus Zfp148-deleted intestinal organoids even at 0.1 mM 
butyrate, while both the Cre Neg and Zfp148-deleted 
organoids without the Apc deletion were already apoptotic 
at this lower butyrate concentration (Figure 7F).
To examine whether ZBP-89 colonic organoids 
exhibited cellular senescence, we determined the levels 
of SA- βGal in organoid cultures treated with increasing 
amounts of butyrate (0, 0.1, 0.5mM) (Figure 8). We found 
that both CreNeg and Cdx2Cre: Zfp148FL/FL organoids 
were senescent and subsequently apoptotic with increasing 
concentrations of butyrate (Figure 8A, 8B, 8E). By 
contrast, Cdx2CreApcFL/+-derived organoids did not 
undergo senescence unless Zfp148 was deleted (Figure 8C-
8E). Since senescence is mediated by the cyclin-dependent 
inhibitor Cdkn2a [20], we determined its expression 
levels using RNA extracted from the organoids before and 
after butyrate treatment. Indeed, we found a significant 
increase in Cdkn2a mRNA with deletion of Zfp148 but 
more dramatically when the organoids were treated with 
butyrate (Figure 8F, 8G). Surprisingly, butyrate strongly 
suppressed Zfp148 gene expression contributing to the 
increase in Cdkn2a (Figure 8F, 8G).
Feng et al. previously showed that ZBP-89 binds 
directly to and represses the CDKN2A promoter in a lung 
cancer cell line by recruiting HDACs [6]. Therefore, to 
determine whether butyrate regulated ZBP-89 binding to 
the Cdkn2a promoter, we performed Chip-Seq using STC-
1 cells, a mouse intestinal cell line and found that ZBP-89 
binding to the mouse Cdkn2a promoter decreases (Figure 
9A). To determine if butyrate suppression of ZBP-89 
binding induced CDKN2A gene expression and senescence 
in colon cancer cell lines, the CRC cell line SW480 was 
treated with butyrate for 1, 3 and 16h. ChiP-qPCR showed 
that butyrate reduced ZBP-89 binding to the CDKN2A 
promoter (Figure 9B), which corresponded to an increase 
Figure 7: Intestinal organoids show greater sensitivity to butyrate than colon organoids. Representative pictures of intestinal 
organoids stained for senescence-associated beta galactosidase (SA-βGal) activity before and after treating with increasing butyrate 
concentrations. (A) Cre Neg., (B) VillinCre:Zfp148FL/FL, (C) VillinCre:ApcFL/+ and (D) VillinCre:ApcFL/+: Zfp148FL/FL. Scale bar=100μm. 
(E) Spectrophotometric quantitation of intestinal organoids SA-βGal activity at A460. (F) TUNEL assay, shown as the percentage of TdT 
positive cells for each population per number of DAPI positive cells. *P< 0.05, **P< 0.001 and ***P< 0.0001 by two-way ANOVA Tukey’s 
multiple comparisons test.
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in CDKN2A gene expression in SW480 in addition to Caco-
2 and HT-29 cell lines (Figure 9C, 9D). To determine if the 
increase in CDKN2A (p16INK4A) expression corresponded 
directly to silencing of ZBP-89 gene expression in the 
colonic cell lines (SW480, Caco-2 and HT-29), ZNF148 
was knocked down using siRNA oligos. Indeed, CDKN2A 
was significantly induced and corresponded to reduced 
ZNF148 mRNA expression (Figure 9E, 9F). Therefore, as 
observed in our mouse model, butyrate induces CDKN2A 
gene expression and presumably cellular senescence 
through its ability to suppress ZNF148 gene expression.
DISCUSSION
The studies reported here demonstrate that ZBP-
89 is expressed in CBCs and plays a role in stem cell 
maintenance and cellular differentiation. We recently 
reported that ZBP-89 synergizes with Wnt signaling 
by directly inducing β-catenin gene expression [9]. 
Consequently, the increase in ZBP-89-mediated gene 
expression sustains elevated levels of this protooncogene. 
Conversely β-catenin induces the expression of ZNF148 
[9]. As previously suggested [9], the feedforward 
regulation of these two transcription factors contributes 
significantly to Wnt-driven transformation from both 
intestine and colonic stem cells [21]. Specifically, we show 
here that fewer and smaller polyps formed when both the 
Zfp148 and Apc loci were conditionally deleted using 
the colon-specific Cdx2Cre transgene. Zfp148 deletion 
corresponded to increased organoid budding indicating 
loss of stemness that presumably retards transformation 
of the colonic stem cell niche. Surprisingly, neither Zfp148 
deletion nor butyrate alone was sufficient to inhibit 
organoid proliferation in the context of a deleted Apc 
Figure 8: Loss of Zfp148 in the presence of butyrate initiates cellular senescence in ApcFL/+ organoids. Representative 
pictures of colonic organoids stained for senescence-associated beta galactosidase (SA-βGal) activity before and after treating with 
increasing butyrate concentrations (A) Cre Neg., (B) Cdx2Cre:Zfp148FL/FL, (C) Cdx2Cre:ApcFL/+ and (D) Cdx2Cre:ApcFL/+: Zfp148FL/FL. 
Scale bar=100μm. (E) Spectrophotometric quantification of colonic organoids SA-βGal activity at A460. (F) qPCR for Cdkn2a and Zfp148 
using three passages of CreNeg and Cdx2: Zfp148FL/FL colonic organoids incubated with 0.1mM butyrate. (G) qPCR for Cdkn2a and Zfp148 
using three passages of Cdx2: ApcFL/+:Zfp148FL/+ and Cdx2: ApcFL/+:Zfp148FL/Fl colonic organoids incubated with 0.5mM butyrate. *P< 0.05, 
**P< 0.001 and ***P< 0.0001 by two-way ANOVA Tukey’s multiple comparisons test.
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locus, but instead synergistically functioned to suppress 
the stem cell phenotype.
HDAC inhibitors such as butyrate induce cellular 
senescence by increasing cyclin-dependent inhibitors, e.g., 
p21waf1, p16INK4 [22-24]. In the colon, butyrate levels are 
lowest in the distal colon and deep within the crypts away 
from luminal bacteria [18, 19]. We previously showed that 
ZBP- 89 directly binds the p21waf1promoter and potentiates 
butyrate induction of this cyclin-dependent inhibitor, 
which is also a gene target of several transcriptional 
regulators including p53 and cMyc [2]. Although ZBP-89 
forms a protein-protein interaction with p53 and prevents 
its nuclear export and degradation in the cytoplasm [3], 
the in vivo significance of the interaction was not readily 
apparent. A possible mechanic was through the induction 
p53 regulation of p21waf1, and subsequently cellular 
senescence. Recently, Lindahl and co-workers reported 
that ZBP-89 blocks Apc mutant polyp development in the 
intestine by inhibiting p53-mediated activity [25]. They 
observed no effect on cell proliferation or apoptosis in 
the early intestinal tumors, and suggested that reduced 
tumor initiation was due to a change in cell fate. Here 
we demonstrate that butyrate coupled with deletion of 
Zfp148 was required to significantly enter a senescent 
phase of slowed cell growth, resulting in fewer and 
smaller colon polyps in vivo as well as fewer and smaller 
Figure 9: Butyrate decreased ZBP-89 binding to the mouse and human p16Ink4a promoter. (A) ChIP-Seq of mouse STC-1 
cells treated with 2.5mM butyrate for 6h. Chromatin precipitated with ZBP-89 antibody was analyzed in the UCSC genome GRC m38/
mm10 browser. (B) Chromatin Immunoprecipitation of SW480 cells treated with butyrate for 1, 3 and 16h. Occupancy of the CDKN2A 
promoter by ZBP-89 determined by qPCR was plotted as a function of the input. (C) SW480, Caco-2 and HT-29 cells treated with butyrate 
for 1, 3 and 16h were analyzed by qPCR for CDKN2A mRNA and (D) ZNF148 mRNA. (E) SW480, Caco-2 and HT-29 cells incubated for 
24h with ZNF148 siRNA or siRNA scrambled control oligos and then treated with butyrate for 1, 3 and 16h were analyzed by qPCR for 
CDKN2A mRNA and (F) ZNF148 mRNA. Shown are means ±SEM, ****P< 0.0001, ***P< 0.001, **P< 0.05, by one-way ANOVA multiple 
comparisons test.
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colonic organoids. As such, ZBP-89 has been shown to 
induce cellular senescence when overexpressed in lung 
cancer cells due to its ability to recruit HDACs to the 
cyclin-dependent inhibitor p16INK4A promoter [6]. Thus, 
a contribution of ZBP-89 to the stem cell phenotype is 
likely related to its ability to recruit HDACs to specific 
promoters regulating the expression of genes that inhibit 
the cell cycle.
Colonic fermentation of dietary carbohydrates is the 
exclusive purview of commensal bacteria with butyrate 
being the most frequently studied of the abundant SCFAs 
[18]. Butyrate exhibits a number of functions ranging 
from colonocyte fuel source to chromatin modulation 
through inhibition of HDACs [26, 27]. Yet, therapy with 
this SCFA to suppress inflammation and transformation 
has been mixed, perhaps as a result of the different 
cellular pathways it regulates [28-30]. Moreover, 
cellular regulation by butyrate depends on the metabolic 
and proliferative status of the cell [31-33]. Typically, 
butyrate levels are lowest in the distal colon due to rapid 
fermentation of dietary fiber and use as a primary carbon 
source by colonocytes in the proximal colon. This in turn 
correlates with the propensity of colorectal tumors to 
develop in the distal colon where butyrate levels are the 
lowest [18, 32]. Indeed, the few polyps that developed in 
the mice carrying deleted Zfp148 alleles were in the distal 
colon. In addition, butyrate levels at the base of the colonic 
crypt where the stem cells reside are estimated to be in the 
micromolar range, significantly lower than the millimolar 
levels at the luminal surface [32]. Consequently, we found 
that treating normal colonic organoids with millimolar 
amounts of butyrate induced senescence and subsequently 
apoptosis. However, organoids from Apc-deleted colons in 
which Wnt signaling is elevated protected against butyrate-
mediated apoptosis and were observed to proliferate. By 
contrast, Zfp148 deletion abolished the protective effect of 
the Apc deletion. Like butyrate, Zimberlin et al. showed 
that intestine specific deletion of both HDAC1 and 
HDAC2 in vivo or chemical ablation with a class I-specific 
HDAC inhibitor MS-275 reduced proliferation, expression 
of stem cell markers and decreased the clonogenic 
capacity of intestinal organoids [34]. Thus, HDACs are an 
essential factor in stem cell maintenance and explains in 
part how ZBP-89 contributes to the stem cell phenotype 
in the colon. We conclude that in both the small intestine 
and colon, ZBP-89 contributes to stem cell maintenance 
as a modulator of the Wnt pathway, but also through 
recruitment of HDACs. However intestinal organoids 
were more sensitive to the senescent and apoptotic effects 
of butyrate than those prepared from the colon. Thus, in 
the colon, where a gradient of butyrate is present as a 
function of the microbiota, we would predict that a ZBP-
89-HDAC complex would inhibit CDKN2A and block 
growth inhibition as a function of being exposed to this 
potent natural HDAC inhibitor.
In summary, ZBP-89 plays an essential role in 
maintaining stemness in both the intestine and colon. As 
a known mediator of butyrate-dependent regulation in 
cell lines [2, 4], it appears that the ability of ZBP-89 to 
interact with HDACs contributes to its ability to synergize 
with β-catenin to resist the senescent effects of butyrate in 
Apc mutant stem cells where Wnt signaling and β-catenin 
protein levels are high. Interestingly, there appears to 
be tissue specific differences in the ability of the small 
intestine versus the colon to resist butyrate-induced 
senescence. Taken together, these results provide at least 
a partial explanation for why ZBP-89 protein expression 
contributes to the formation of colonic adenomas and 
progression during the early stages colon cancer [9, 35].
MATERIALS AND METHODS
Animal models
Generation of Zfp148FL/FL mice on a C57BL/6 
genetic background was previously described [8]. 
ApcFL/+, Zfp148FL/+ and Zfp148FL/FL  mice were bred to the 
Cdx2Cre mouse line [14] or VillinCre [36] to generate 
mice that were heterozygous for the Apc allele alone or 
with the Zfp148FL/+ and Zfp148FL/FL genotypes (Cdx2Cre: 
ApcFL/+:Zfp148FL/FLor ApcFL/+:Zfp148FL/+ or VillinCre: 
ApcFL/+:Zfp148FL/FL [9]). To generate the Zfp148CreERT2 
transgene, the CreERT2_IRES_eGFP cDNA cassette was 
inserted downstream of the mouse Zfp148 ATG in exon 4 
prepared from BAC clone RP23-207B1 that contains 250 
kb of the Zfp148 mouse gene (JrGang Cheng, University 
of North Carolina). The purified Zfp148CreERT2 transgene 
was microinjected into the pronuclei of fertilized C57BL/6 
x SJL chimeric mouse eggs (University of Michigan 
Transgenic Core). Three founder lines (725, 730 and 
740) were bred to the Rosa26-LoxSTOPLox-tdTomato 
reporter mice (Rosa-tdT) (B6.Cg-Gt(ROSA)26Sortm27.1(CAG-
COP4*H134R/tdTomatoHze/J strain 012567) purchased from Jackson 
Laboratory. The lines were ultimately backcrossed to 
C57BL/6 mice over two years. To lineage trace Zfp148 
expression in the intestine and colon, the line with the 
highest fluorescent reporter expression was selected 
(line 730). Mice were maintained under the University 
of Michigan Animal Care and Use Committee, which 
maintains an American Association of Assessment and 
Accreditation of Laboratory Animal Care facility and 
approved all methods and procedures used.
Immunohistochemistry
Immunohistochemistry was performed using the 
diaminobenzidine (DAB)-based staining technique (Abcam, 
ab4238). After de-paraffinization and rehydration, antigen 
retrieval was performed by boiling tissue sections in a 
microwave for 10min with 10mM sodium citrate buffer (pH 
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6.0). Tissue sections were preincubated with 0.3% hydrogen 
peroxide and nonspecific binding sites were blocked with 
20% normal goat serum (Jackson ImmunoResearch, 
West Grove. PA). A polyclonal antibody to the conserved 
C- terminal residues (611-794) of ZBP-89 (1:1000, sc-
48811; Santa Cruz Biotechnology Inc., Santa Cruz, CA) 
was incubated for 2h in a humidified chamber and then 
incubated with horseradish peroxidase (HRP)- conjugated 
secondary antibody for 30min. The sections were stained 
with DAB and counterstained with Mayer hematoxylin, 
prior to mounting in Toluene Permount (Fisher Scientific, 
Waltham, MA).
In situ hybridization
The tissue was embedded in O.C.T. Compound 
(Tissue –Tek), sectioned, placed on slides and then was 
re-hydrated in DEPC-treated water prior to a 1h pre-
hybridization incubation in 50% formamide/Denhardt’s 
solution at 55°C. The single strand DNA probes (ssDNA) 
labeled at the 5’ end with 6-FAM were reconstituted 
in sterile RNAse-free water, diluted to a working 
concentration of 50ng/ml with hybridization buffer and 
incubated for 48h at 60°C. Slides were stringently washed 
with 50% formamide in 5X sodium citrate saline (SSC, 
pH 7.0) buffer for 2min at 40°C. Samples were rinsed 
with DEPC-treated water and allowed to air-dry prior to 
mounting with Prolong Gold Antifade reagent with DAPI 
(ThermoFisher; Scientific). The following probes were 
used:
Zfp148 antisense probe 1: 5’6-FAM/ACCGACT 
ATTAGTCCAAAGTGGGACTT/
Zfp148 sense probe: 5’6-FAM/TGGCTGATAA 
TCAGGTTTCACCCTGAA/
Sense strand sequence for Zfp148 was used as 
negative control.
Mouse organoid generation
Intestinal or colonic mucosa was minced into 5mm 
pieces on ice followed by gland dissociation in 2mM 
EDTA/PBS at 4°C for 30min for intestinal tissue and 4mM 
EDTA/PBS at 4°C for 60min for colonic tissue. After 
filtration through a 70μm cell strainer (BD Bioscience) 
for intestine and a 100μm cell strainer (BD Bioscience) for 
colon, the suspension was centrifuged at 200×g for 5min. 
Intestinal glands were re-suspended in 50μl of Matrigel 
supplemented with Advanced DMEM/F12 (Invitrogen) 
containing 50% of Wnt, R-Spondin, Noggin conditioned 
media generated from the L-WRN (cell line ATCC® CRL-
3276™) with B27 and N2 1X supplements (ThermoFisher; 
Scientific) plus EGF (50ng/ml, Invitrogen). To generate 
colon organoids, the media was mixed with Matrigel 
containing CHIR99021 (10mM, STEMCELL), Y-27632 
(10mM, STEMCELL), A83-01 (500nM, Sigma-Aldrich) 
and gastrin (10nM, Sigma-Aldrich). The organoid preps 
were cultured at 37°C in 5% CO2. Butyrate treatment of 
intestinal or colonic organoids was performed 3 days after 
the organoids became established in Advanced DMEM/
F12 media. Upon receipt, frozen stocks were generated 
for the L-WRN cells and were checked for mycoplasma 
every 3 months. EdU staining of colonic organoids was 
performed for 16h using the Click-iT® EdU Imaging 
Kit and was developed according to manufacturer’s 
instructions. EdU incorporation was quantified using the 
program Cellprofiler (http://cellprofiler.org/) comparing 
EdU area to DAPI stained nuclei per image [37]. Five 
images per passage of organoids derived from 3 mice per 
genotype per condition were analyzed.
In vitro tamoxifen induction
To activate the CreERT2 transgene in culture, 
the organoids were incubated with low dose 
4-hydroxytamoxifen (4-OH-Tx, 100nM) for 24h in 
complete Advanced DMEM/F12, (Invitrogen). After the 
incubation, the cultures were washed with PBS and then 
fresh complete media was added.
Real-time quantitative PCR
Total RNA from intestine and colon was 
extracted and purified, using the PureLink RNA Mini 
Kit (ThermoFisher). RNA (1μg) was DNAse-treated 
(Promega) and used to generate cDNA using the iScript 
reverse transcriptase kit (Bio-Rad, Hercules, CA). Real-
time quantitative polymerase chain reaction (RT-qPCR) 
was performed using Platinum Taq DNA polymerase 
(Invitrogen) on a CFX96 real-time PCR detection system 
(Bio-RAD), using the following primer sequences (Tm = 
65°C for all primers):
Zfp148: F: 5’ TCCAAACCACTGATTCTTCTCTT; 
R: 5’ AGTTCTCTCCCCTCCCCCT
Lgr5: F: 5’ TCTTCTAGGAAGCAGAGGCG; R: 5’ 
CAACCTCAGCGTCTTCACCT
Cdkn2: F: GCAGAAGAGCTGCTACGTGA; R: 5’ 
CGTGAACATGTTGTTGAGGC
Cdx2: F: 5’ TCTGTGTACACCACCCGGTA; R: 5’ 
GAAACCTGTGCGAGTGGATG
Reg4: F: 5’ GCACAGCTGGGTCTCAAGAT; R: 5’ 
CATCGAAAGAGGAAGATGGC
Axin2: F: 5’ TGCATCTCTCTCTGGAGCTG; R: 5’ 
ACTGACCGACGATTCCATGT
Notch1: F: 5’ CTGAGGCAAGGATTGGAGTC; R: 
5’ GAATGGAGGTAGGTGCGAAG
Ctnnb1: F: 5’ CAGCTTGAGTAGCCATTGTCC; R: 
5’ GAGCCGTCAGTGCAGGAG.
Flow cytometry and cell sorting
Isolated crypts were incubated in culture medium 
for 45min at 37°C, followed by cell dissociation using 
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Accutase (STEMCELL) for 15min at 37°C. Dissociated 
cells were filtered through a 40μm pore cell strainer 
(BD Bioscience). TdTomato positive cells were sorted 
by flow cytometry using an iCyt Synergy Flow sorter 
(Sony Biotechnology). Single viable epithelial cells 
from both the intestine and colon were gated by forward 
scatter, side scatter, pulse-width parameter and by 
negative staining for DAPI (Sigma Aldrich). Sorted 
cells were collected in crypt culture medium, embedded 
in Matrigel and then overlaid with complete culture 
media.
TUNEL assay
Three-day old small intestine or colonic organoids 
were resuspended in cold cell dissociation with 2mM 
EDTA/PBS and incubated at 4°C for 10min, and then 
filtered through a 40μm cell strainer (BD Bioscience). The 
suspension was centrifuged at 200×g for 5 min, pelleted 
and then resuspended in 1ml of 3.7% formaldehyde. After 
incubating for 10 min, the fixed cells were washed in cold 
PBS and labeled using the TACS 2 TdT fluorescein kit 
according to manufacturer’s procedure (Trevigen, MD). 
The total number of TdT positive cells for each population 
was calculated using gating percentage multiplied by total 
number of cells labeled with DAPI (Sigma Aldrich). 
Analysis was performed using FlowJo software (TreeStar, 
Ashland OR).
Senescence-associated galactosidase activity 
assay
Galactosidase activity was quantified in intestinal 
and colonic organoids using the Senescence Cells 
Histochemical Staining kit (Sigma Aldrich) according 
to manufacturer’s instructions. Staining was developed 
over 10h and visualized in an inverted optical microscope 
(Leica). For quantitation, intestinal or colonic organoids 
were lysed in RIPA buffer (ThermoFisher) for 10min and 
centrifuged at 10,000×g for 5min, the supernatant was 
collected and the absorbance was measured on a plate 
reader at A460.
Chromatin immunoprecipitation (ChIP)
SW480 cells were treated with 1% formaldehyde 
and then quenched with glycine for 5min at room 
temperature. Cell lysates were sonicated to shear DNA 
into fragments of 200 to 1000bp (8 cycles of 30 second 
intervals) using a 130W Sonic Vibracell (VCX130PB). 
An aliquot (5%) of the lysates was removed and used 
as the Input, while the remaining solution was used to 
immunoprecipitate cross-linked protein using a ZBP-89 
monoclonal antibody and an IgG antibody as control. 
Immune complexes were captured using Protein A/G 
agarose beads, after washing, bound proteins were eluted 
from the beads and diluted 1:15 in deionized water (EZ 
Magna ChIP A/G kit, Millipore). After proteinase K 
and RNase A digestions, purified DNA was analyzed by 
PCR using NovaTap DNA polymerase (Millipore) using 
flanking promoter primers for CDKN2A and primers for 
chromogranin A (ChrA), a gene not regulated by ZBP-
89. ChIP-qPCR values were expressed as a percentage of 
Input DNA.
ChIP-seq
Mouse STC-1 cells were treated with 2.5 mM 
butyrate for 6h before adding 1% formaldehyde. After 
performing chromatin immunoprecipitation (ChIP) with 
ZBP-89 antibody (Santa Cruz, CA), generation of the 
library and Illumina sequencing was performed by the 
UM Sequencing Core. Conversion of the sequences into 
Fastq was performed using Illumina’s CASAVA-1.8.2 
software. Q-Scores were determined using ASCII+33. 
Genomic signatures were analyzed for GC-rich ZBP-89 
consensus sites within 1kb of the transcriptional start 
sites (TSS). Duplicate sequencing reads per treatment 
were aligned to the Mouse GRC m38/mm10 and BAM 
files were converted to BigWig for analysis in the UCSC 
genome browser.
Statistical analysis
Two-way ANOVA with Tukey’s multiple 
comparisons test was performed to analyze the number of 
organoids and cell proliferation assays. One-way ANOVA 
with Kruskal-Wallis multiple comparisons test was used 
to compare the number of polyps per genotype. Two-
way ANOVA with Sidak’s multiple comparisons test was 
used to compare the size of organoids per genotype per 
condition.
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